RPG Life Sciences balance sheet

As of Sep 2026

Total assets: ₹1,116cr
Shareholders' equity: ₹866cr
Total debt: ₹22.3cr
Cash and investments: ₹273cr

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	351	192	322	194	203
	20.4	20.0	4.0	84.8	15.0
	0.0	1.0	—	—	—
	6.8	0.0	—	—	—
	48.7	4.8	10.7	16.5	23.0
	3.3	3.3	12.1	11.5	10.4
	2.5	0.4	1.0	1.0	—
	0.2	0.1	—	—	—
	1.6	7.0	10.2	—	1.7
	4.2	7.6	—	—	—
	0.0	0.0	1.0	0.6	—
	5.4	—	0.5	1.5	3.3
	439	228	193	215	155
	173	124	93.0	101	95.1
	162	83.9	126	90.2	—
	141	117	86.8	49.1	37.4
	111	150	28.7	19.7	24.8
	19.4	41.1	111	16.8	32.2
	1.2	9.3	—	—	—
	61.9	34.2	—	—	—
	497	436	358	177	—
	—	—	14.2	20.3	14.7
	677	565	465	298	264
	1,116	793	658	513	419
Equity
	13.2	13.2	13.2	13.2	13.2
	674	592	517	362	294
	687	605	531	375	308
	179	—	—	—	—
	866	605	531	375	308
Liabilities
	0.6	13.3	—	—	—
	7.6	3.4	2.9	3.0	3.0
	8.2	16.8	—	—	3.0
	7.4	7.4	4.5	4.0	4.0
	5.1	3.1	—	—	2.0
	20.7	27.2	7.5	7.1	9.0
	21.7	6.7	—	—	—
	106	97.2	79.4	71.0	64.7
	28.0	20.4	17.6	39.8	20.0
	156	124	97.0	—	84.7
	9.8	29.1	16.1	12.2	11.9
	6.5	1.2	—	—	—
	57.2	5.9	6.7	5.2	6.2
	229	161	120	131	103
	250	188	127	138	112
	1,116	793	658	513	—
Assets — additional as-filed lines
	7.0	5.3	—	—	—
Trade payables — MSME split
	8.0	5.1	—	—	—
	98.1	92.1	—	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RPGLIFE₹2,844.00

RPG Life Sciences Limited

· Pharma & Health

₹ CrorePeersGUFICBIO GUJTHEM UNICHEMLAB ORCHPHARMA SMSPHARMA FDC IOLCP INDSWFTLABMcap ₹4,703 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	202.5	194.1	322.4	191.7	350.5
+ Capital Work-in-Progress	15.0	84.8	4.0	20.0	20.4
+ Investment Property	—	—	—	1.0	0.0
+ Goodwill	—	—	—	0.0	6.8
+ Other Intangibles	23.0	16.5	10.7	4.8	48.7
+ Intangibles under Development	10.4	11.5	12.1	3.3	3.3
+ Non-current Investments	—	1.0	1.0	0.4	2.5
+ Long-term Loans	—	—	—	0.1	0.2
+ Other Non-current Financial Assets	1.7	—	10.2	7.0	1.6
Non-current Financial Assets	—	—	—	7.6	4.2
+ Deferred Tax Assets	—	0.6	1.0	0.0	0.0
+ Other Non-current Assets	3.3	1.5	0.5	—	5.4
Total Non-current Assets	155.3	214.8	192.6	228.4	439.3
Current Assets
+ Inventories	95.1	101.0	93.0	123.8	173.4
+ Current Investments	—	90.2	125.9	83.9	162.3
+ Trade Receivables	37.4	49.1	86.8	116.7	141.4
+ Cash & Cash Equivalents	24.8	19.7	28.7	150.5	110.5
+ Other Bank Balances	32.2	16.8	110.9	41.1	19.4
+ Short-term Loans	—	—	—	9.3	1.2
+ Other Current Financial Assets	—	—	—	34.2	61.9
Current Financial Assets	—	176.8	358.1	435.6	496.7
+ Other Current Assets	14.7	20.3	14.2	—	—
Total Current Assets	264.1	298.1	465.3	564.8	677.1
Total Assets	419.4	512.9	657.8	793.2	1,116.4
Equity
+ Equity Share Capital	13.2	13.2	13.2	13.2	13.2
+ Other Equity / Reserves	294.4	361.6	517.3	592.2	674.0
Equity — Owners of Parent	307.6	374.9	530.5	605.4	687.2
+ Minority Interest	—	—	—	—	179.3
Total Equity	307.6	374.9	530.5	605.4	866.5
Liabilities
+ Borrowings — Non-current	—	—	—	13.3	0.6
+ Other Non-current Financial Liab	3.0	3.0	2.9	3.4	7.6
Non-current Financial Liabilities	3.0	—	—	16.8	8.2
+ Provisions — Non-current	4.0	4.0	4.5	7.4	7.4
+ Deferred Tax Liabilities	2.0	—	—	3.1	5.1
Non-current Liabilities	9.0	7.1	7.5	27.2	20.7
+ Borrowings — Current	—	—	—	6.7	21.7
+ Trade Payables	64.7	71.0	79.4	97.2	106.0
+ Other Current Financial Liab	20.0	39.8	17.6	20.4	28.0
Current Financial Liabilities	84.7	—	97.0	124.3	155.7
+ Provisions — Current	11.9	12.2	16.1	29.1	9.8
+ Current Tax Liabilities	—	—	—	1.2	6.5
+ Other Current Liabilities	6.2	5.2	6.7	5.9	57.2
Current Liabilities	102.8	131.0	119.8	160.5	229.2
Total Liabilities	111.8	138.0	127.3	187.8	249.9
Total Equity & Liabilities	—	512.9	657.8	793.2	1,116.4
Assets — additional as-filed lines
+ Current Tax Assets	—	—	—	5.3	7.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	—	5.1	8.0
+ Dues to Other Creditors — Current	—	—	—	92.1	98.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.